ICI
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
June, 2024
June 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
« May
ICI
May 31, 2024, 02:35 |
Blog
Biagio Ricciuti: Great conversation on the role of ICI in patients with NSCLC and driver mutations
Biagio Ricciuti shared a post by Narjust Florez on X, adding: , "I had a…
May 19, 2024, 14:01 |
Insight
Arielle Elkrief: Excited to launch this pan Canadian phase 2 RCT of FMT and ICI in melanoma
Arielle Elkrief, Assistant Professor and Principal Scientist at University of Montreal, shared a post by…
May 17, 2024, 17:53 |
Insight
Piotr Wysocki: Better responses to immunotherapy in NSCLC patients with rare EGFR mutation
Piotr Wysocki recently posted on LinkedIn: "The efficacy of immune checkpoint inhibitors (ICI) as monotherapy in…
Apr 4, 2024, 20:02 |
Drugs
Georges Gebrael: RWD of Cabozantinib and ICI vs. cabozantinib monotherapy align with CONTACT03 trial results
Georges Gebrael, Research Fellow at Huntsman Cancer Institute and University of Utah, shared on X/Twitter:…
Apr 4, 2024, 14:05 |
Insight
Toni Choueiri: More evidence that ICI after ICI may not be effective
Toni Choueiri, Professor of Medicine at Harvard Medical School and Director of the Lank Center…
Mar 16, 2024, 10:49 |
Blog
Deniz Can Guven: We reviewed the available evidence regarding ICI use in patients with frailty
Deniz Can Guven, Medical Oncologist at Health Sciences University, Elazığ City Hospital, recently shared on…
Mar 12, 2024, 20:33 |
Insight
Jarushka Naidoo: Is chemo-ICI or ICI preferable, in patients older than 75yrs with advanced NSCLC?
Jarushka Naidoo shared on X/Twitter: "Is chemo-ICI or ICI preferable, in pts >75yrs with advanced…
All:
7
Posts:
1 - 10
New Paper Alert! Long-Term Benefits of Dabrafenib-Trametinib in Stage III Melanoma: 8-Year COMBI-AD Trial Results
We mourn the loss of our Ivy Elkins
FDA grants accelerated approval to adagrasib with cetuximab for KRAS G12C-mutated colorectal cancer
Rob Winn: Honored to receive the ASCO Allen Lichter Visionary Leader Award
Yardena Samuels: An absolute honor to be elected as the next EACR president
Facebook
RSS Feed
Twitter
Linkedin
Youtube